Tyrvaya increases Schirmer score in dry eye patients

July 06, 2022

1 minute watch



O’Dell L, et al. Effect of OC-01 nasal spray (varenicline solution) versus vehicle control on dry eye sign scores by baseline subgroup characteristics.

O’Dell declares to be a member of the advisory board of Oyster Point Pharma.

We have not been able to process your request. Please try again later. If you continue to have this problem, please contact [email protected]

CHICAGO – Tyrvaya nasal spray was shown to increase Schirmer scores within 4 weeks in the ONSET-1 and ONSET-2 clinical trials, Leslie O’Dell, DO, said at the optometry meeting.

Patients using OC-01 or Tyrvaya (Varenicline Solution 0.03 mg, Oyster Point Pharma) increased by 5.5 mm whether or not they started with mild or severe dry eye disease, she said. .

Comments are closed.